Status:
RECRUITING
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Gynecological Tumors.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Gynecological Tumors
Eligibility:
FEMALE
18+ years
Brief Summary
Gynecological cancers involve several tumors of the female reproductive system. The five most common gynecological tumors are those of the uterine cervix, endometrium, ovary, vagina and vulva. Further...
Eligibility Criteria
Inclusion
- adult patients suffering from a gynecological oncological disease; Patients who have performed at least one PET study with 18F FDG for the staging or restaging of their oncological pathology; patients who give written informed consent to the study
Exclusion
- patients \<18 years lack of availability of clinical and PET imaging data useful for analyses.
Key Trial Info
Start Date :
October 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 27 2024
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT06159907
Start Date
October 27 2021
End Date
December 27 2024
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italia, Italy